Human Genome Epidemiology Literature Finder
|
Records 1 - 27 (of 27 Records) |
| Query Trace: Neoplasms and PPM1D[original query] |
|---|
| Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature 2012 Dec . Ruark E, Snape K, Humburg P, Loveday C, Bajrami I, Brough R, Rodrigues DN, Renwick A, Seal S, Ramsay E, Duarte SD, Rivas MA, Warren-Perry M, Zachariou A, Campion-Flora A, Hanks S, Murray A, Pour NA, Douglas J, Gregory L, Rimmer A, Walker NM, Yang TP, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Eccles D, Evans DG, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Gore M, Houlston R, Brown MA, Caufield MJ, Deloukas P, McCarthy MI, Todd JA, Turnbull C, Reis-Filho JS, Ashworth A, Antoniou AC, Lord CJ, Donnelly P, Rahman N |
| PPM1D mutations in circulating white blood cells and the risk for ovarian cancer. Journal of the National Cancer Institute 2013 Nov . Akbari MR, Lepage P, Rosen B, McLaughlin J, Risch H, Minden M, Narod SA |
| Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients. British journal of cancer 2015 Mar 112 (6): 1114-20. Zajkowicz A, Butkiewicz D, Drosik A, Giglok M, Suwi?ski R, Rusin |
| Truncating and missense PPM1D mutations in early-onset and/or familial/hereditary prostate cancer patients. Genes, chromosomes & cancer 2016 Jul . Cardoso Marta, Paulo Paula, Maia Sofia, Teixeira Manuel |
| Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma. JAMA oncology 2016 Feb . Swisher Elizabeth M, Harrell Maria I, Norquist Barbara M, Walsh Tom, Brady Mark, Lee Ming, Hershberg Robert, Kalli Kimberly R, Lankes Heather, Konnick Eric Q, Pritchard Colin C, Monk Bradley J, Chan John K, Burger Robert, Kaufmann Scott H, Birrer Michael |
| PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. Journal of the National Cancer Institute 2016 Mar 108 (3): . Pharoah Paul D P, Song Honglin, Dicks Ed, Intermaggio Maria P, Harrington Patricia, Baynes Caroline, Alsop Kathryn, , Bogdanova Natalia, Cicek Mine S, Cunningham Julie M, Fridley Brooke L, Gentry-Maharaj Aleksandra, Hillemanns Peter, Lele Shashi, Lester Jenny, McGuire Valerie, Moysich Kirsten B, Poblete Samantha, Sieh Weiva, Sucheston-Campbell Lara, Widschwendter Martin, , Whittemore Alice S, Dörk Thilo, Menon Usha, Odunsi Kunle, Goode Ellen L, Karlan Beth Y, Bowtell David D, Gayther Simon A, Ramus Susan |
| Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. Cell stem cell 2017 Aug . Coombs Catherine C, Zehir Ahmet, Devlin Sean M, Kishtagari Ashwin, Syed Aijazuddin, Jonsson Philip, Hyman David M, Solit David B, Robson Mark E, Baselga José, Arcila Maria E, Ladanyi Marc, Tallman Martin S, Levine Ross L, Berger Michael |
| Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer. Clinical breast cancer 2017 12 18 (4): e643-e650. Inoue Yuka, Yamashita Nami, Kitao Hiroyuki, Tanaka Kimihiro, Saeki Hiroshi, Oki Eiji, Oda Yoshinao, Tokunaga Eriko, Maehara Yoshihi |
| Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial. Human mutation 2018 Sep . Weber-Lassalle Konstantin, Harter Philipp, Hauke Jan, Ernst Corinna, Kommoss Stefan, Marmé Frederik, Weber-Lassalle Nana, Prieske Katharina, Dietrich Dimo, Borde Julika, Pohl-Rescigno Esther, Reuss Alexander, Ataseven Beyhan, Engel Christoph, Stingl Julia C, Schmutzler Rita K, Hahnen Er |
| Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings. Journal of cancer research and clinical oncology 2018 10 144 (12): 2495-2513. Bonache Sandra, Esteban Irene, Moles-Fernández Alejandro, Tenés Anna, Duran-Lozano Laura, Montalban Gemma, Bach Vanessa, Carrasco Estela, Gadea Neus, López-Fernández Adrià, Torres-Esquius Sara, Mancuso Francesco, Caratú Ginevra, Vivancos Ana, Tuset Noemí, Balmaña Judith, Gutiérrez-Enríquez Sara, Diez Orla |
| Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer. Endocrine 2018 Sep . Alzahrani Ali S, Murugan Avaniyapuram Kannan, Qasem Ebtesam, Alswailem Meshael M, AlGhamdi Balgees, Moria Yosra, Al-Hindi Hin |
| Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy. PloS one 2019 14 (6): e0217521. Kim Borahm, Won Dongju, Lee Seung-Tae, Choi Jong R |
| Somatic genetic alterations in a large cohort of pediatric thyroid nodules. Endocrine connections 2019 May . Pekova Barbora, Dvorakova Sarka, Sykorova Vlasta, Vacinova Gabriela, Vaclavikova Eliska, Moravcova Jitka, Katra Rami, Vlcek Petr, Sykorova Pavla, Kodetova Daniela, Vcelak Josef, Bendlova Be |
| Detectible mosaic truncating PPM1D mutations, age and breast cancer risk. Journal of human genetics 2019 Mar . Machiela Mitchell J, Myers Timothy A, Lyons Christopher J, Koster Roelof, Figg William D, Colli Leandro M, Jessop Lea, Ahearn Thomas U, Freedman Neal D, García-Closas Montserrat, Chanock Stephen |
| Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis. Journal of geriatric oncology 2019 Sep . Slavin Thomas P, Sun Can-Lan, Chavarri-Guerra Yanin, Sedrak Mina S, Katheria Vani, Castillo Danielle, Herzog Josef, Dale William, Hurria Arti, Weitzel Jeffrey |
| Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nature communications 2020 6 11 (1): 2996. Mouhieddine Tarek H, Sperling Adam S, Redd Robert, Park Jihye, Leventhal Matthew, Gibson Christopher J, Manier Salomon, Nassar Amin H, Capelletti Marzia, Huynh Daisy, Bustoros Mark, Sklavenitis-Pistofidis Romanos, Tahri Sabrin, Hornburg Kalvis, Dumke Henry, Itani Muhieddine M, Boehner Cody J, Liu Chia-Jen, AlDubayan Saud H, Reardon Brendan, Van Allen Eliezer M, Keats Jonathan J, Stewart Chip, Mehr Shaadi, Auclair Daniel, Schlossman Robert L, Munshi Nikhil C, Anderson Kenneth C, Steensma David P, Laubach Jacob P, Richardson Paul G, Ritz Jerome, Ebert Benjamin L, Soiffer Robert J, Trippa Lorenzo, Getz Gad, Neuberg Donna S, Ghobrial Irene |
| Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer. Cancers 2020 4 12 (4): . Lhotova Klara, Stolarova Lenka, Zemankova Petra, Vocka Michal, Janatova Marketa, Borecka Marianna, Cerna Marta, Jelinkova Sandra, Kral Jan, Volkova Zuzana, Urbanova Marketa, Kleiblova Petra, Machackova Eva, Foretova Lenka, Hazova Jana, Vasickova Petra, Lhota Filip, Koudova Monika, Cerna Leona, Tavandzis Spiros, Indrakova Jana, Hruskova Lucie, Kosarova Marcela, Vrtel Radek, Stranecky Viktor, Kmoch Stanislav, Zikan Michal, Macurek Libor, Kleibl Zdenek, Soukupova Ja |
| Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study. Leukemia 2020 Mar . Husby Simon, Favero Francesco, Nielsen Christian, Sørensen Betina S, Bæch John, Grell Kathrine, Hansen Jakob W, Rodriguez-Gonzalez Francisco G, Haastrup Eva K, Fischer-Nielsen Anne, Andersen Pernille, Arboe Bente, Sækmose Susanne G, Hansen Per B, Christiansen Ilse, Clasen-Linde Erik, Meldgaard Lene, Ebbesen Lene H, Segel Erik K, Josefsson Pär, Thorsgaard Michael, El-Galaly Tarec C, Brown Peter, Weischenfeldt Joachim, Larsen Thomas S, Grønbæk Kirst |
| Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer. Journal of the National Cancer Institute 2021 12 114 (4): 565-570. Weber-Lassalle Konstantin, Ernst Corinna, Reuss Alexander, Möllenhoff Kathrin, Baumann Klaus, Jackisch Christian, Hauke Jan, Dietrich Dimo, Borde Julika, Park-Simon Tjoung-Won, Hanker Lars, Prieske Katharina, Schmidt Sandra, Weber-Lassalle Nana, Pohl-Rescigno Esther, Kommoss Stefan, Marmé Frederik, Heitz Florian, Stingl Julia C, Schmutzler Rita K, Harter Philipp, Hahnen Er |
| Germline Mutations in Patients With Early-Onset Prostate Cancer. Frontiers in oncology 2022 6 12 826778. Tang Tang, Tan Xintao, Wang Ze, Wang Shuo, Wang Yapeng, Xu Jing, Wei Xiajie, Zhang Dianzheng, Liu Qiuli, Jiang J |
| Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
| Mutational Landscape of Normal Human Skin: Clues to Understanding Early-Stage Carcinogenesis in Keratinocyte Neoplasia. The Journal of investigative dermatology 2023 1 . Kim Yoon-Seob, Bang Chul Hwan, Chung Yeun-J |
| Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescuing and cancer mutations. Blood 2024 9 . Fernanda Gutierrez-Rodrigues, Emma M Groarke, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, Luiz Fernando Bazzo Catto, Marena Rebekka Niewisch, Ruba N Shalhoub, Lisa J McReynolds, Diego V Clé, Bhavisha A Patel, Xiaoyang Ma, Dalton Hironaka, Flavia S Donaires, Nina R Spitofsky, Barbara A Santana, Tsung-Po Lai, Lemlem Alemu, Sachiko Kajigaya, Ivana Darden, Weiyin Zhou, Paul V Browne, Subrata Paul, Justin Lack, David J Young, Courtney D DiNardo, Abraham Aviv, Feiyang Ma, Michel Michels de Oliveira, Ana Paula de Azambuja, Cynthia E Dunbar, Malgorzata Olszewska, Emmanuel Olivier, Eirini P Papapetrou, Neelam Giri, Blanche P Alter, Carmem M S Bonfim, Colin O Wu, Guillermo Garcia-Manero, Sharon A Savage, Neal S Young, Simona Colla, Rodrigo T Cala |
| Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China. International journal of cancer 2024 8 . Xi Dou, Chunli Dan, Duanzhong Zhang, Hongjing Zhou, Renke He, Guangyu Zhou, Yu Zhu, Nan Fu, Ben Niu, Shuangnian Xu, Yi Liao, Zhangqin Luo, Lihua Yang, Haiguo Zhang, Yizhi Xu, Qian Zhan, Wei Chen, Zesong Yang, Xiaoqiong Tang, Hongbin Zhang, Qing Xiao, Jianbin Chen, Lin Liu, Yi Wang, Li Pei, Li Wa |
| The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. Cancer genomics & proteomics 2024 8 21 (5): 448-463. Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, Christina Ntogka, Georgia Pepe, Dimitra Bouzarelou, Athanasios Papathanasiou, Dimitrios Grigoriadis, Georgios N Tsaousis, Helen Gogas, Theodore Troupis, Konstantinos Papazisis, Ioannis Natsiopoulos, Vassileios Venizelos, Kyriakos Amarantidis, Stylianos Giassas, Christos Papadimitriou, Elena Fountzilas, Maroulio Stathoulopoulou, Anna Koumarianou, Grigorios Xepapadakis, Alexandru Blidaru, Daniela Zob, Oana Voinea, Mustafa Özdo?an, Mahmut Çerkez Ergören, Alinta Hegmane, Eirini Papadopoulou, George Nasioulas, Christos Markopoul |
| Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate 2024 4 . Catherine H Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarak |
| Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer. Leukemia 2024 4 . Christopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, Natalia Estrada, Friederike Christen, Ute Martha Moll, Robert Zeillinger, Wolfgang Daniel Schmitt, Jalid Sehouli, Hagen Kulbe, Maximilian Fleischmann, Isabelle Ray-Coquard, Alain Zeimet, Francesco Raspagliesi, Claudio Zamagni, Ignace Vergote, Domenica Lorusso, Nicole Concin, Lars Bullinger, Elena Ioana Braicu, Frederik Da |
- Page last reviewed:Feb 1, 2024
- Content source: